# CISCO-21 Prevent and Treat Long COVID-19.

> **NCT04900961** · NA · COMPLETED · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 233 (actual)

## Conditions studied

- Covid19

## Interventions

- **OTHER:** Resistance Exercise

## Key facts

- **NCT ID:** NCT04900961
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2024-08-30
- **Final completion:** 2025-02-21
- **Target enrollment:** 233 (ACTUAL)
- **Last updated:** 2025-02-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04900961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04900961, "CISCO-21 Prevent and Treat Long COVID-19.". Retrieved via AI Analytics 2026-09-15 from https://api.ai-analytics.org/clinical/NCT04900961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*